Internal Medicine, Family Medicine

Lipids Management

Michael W. Cullen, MD

Lipid Management: Using the Pooled Cohort Risk Assessment tool, treating to the LDL-C Goal, and non-statin lipid medications

Share via Email

Jump to...

  • 1:27

    Case: 59-year-old male

  • 2:58

    Statin Therapy: When to use as Secondary and Primary Therapy

  • 4:36

    Statin Therapy - Select and Doses

  • 6:42

    Assess Cardiovascular: Pooled Cohort Risk Assessment Calculator

  • 9:51

    Considerations when applying the Risk Calculator

  • 11:14

    Case: 59-year-old male: Initial treatment option

  • 12:29

    Case Study: 6 months after selected treatment option

  • 13:53

    Treating to LDL-C Goal

  • 17:08

    Considerations when to treat to the LDL-C Goal

  • 17:51

    Case: 12-months after treatment

  • 19:34

    High-Intensity Statin Therapy

  • 20:29

    Ezetimibe

  • 23:42

    Evolocumabe

  • 25:47

    Evolocumabe and Alirocoumab :When to Use

  • 28:25

    Other Non-Statin Medications

  • 29:09

    Case 1: Treatment Recommendations for 12-months after treatment

  • 30:15

    Summary